Description

Enclomiphene – 12.5mg

(Selective Estrogen Receptor Modulator – SERM)

Enclomiphene is a nonsteroidal selective estrogen receptor modulator (SERM) and the trans-isomer of clomiphene citrate. It acts primarily as an estrogen receptor antagonist in the hypothalamus and pituitary gland, blocking estrogen-mediated negative feedback. This results in increased gonadotropin-releasing hormone (GnRH) secretion, elevated luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and subsequent stimulation of endogenous testosterone production in research models.

Enclomiphene has been investigated as a potential alternative to testosterone replacement therapy, with studies focusing on its ability to restore and maintain physiological testosterone levels while preserving fertility.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• Antagonizes estrogen receptors in the hypothalamus and pituitary

• Increases GnRH release, stimulating LH and FSH secretion

• Enhances endogenous testosterone production while maintaining spermatogenesis

• Functions as a SERM with tissue-selective activity (antagonist in the hypothalamus, partial agonist elsewhere)

---

Potential Benefits (Based on Preclinical Research):

• Studied for boosting endogenous testosterone without suppressing fertility

• Explored as an alternative to exogenous testosterone therapy in male models

• Potential benefits for maintaining sperm count and reproductive function

• Investigated for modulation of estrogen-sensitive pathways with reduced risk of feminizing effects compared to clomiphene mixtures

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.